研究领域
• 暂无内容

论文成果 More>>
• . Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multicenter randomized controlled trial.  《JOURNAL OF GASTROENTEROLOGY》,  2025. 
• 陶子文. Risk of Severe COVID-19 Increased by Metabolic Dysfunction-associated Fatty Liver Disease A Meta-analysis.  JOURNAL OF CLINICAL GASTROENTEROLOGY,  55,  830, 2025. 
• . Transarterial Chemoembolization Combined With Endoscopic Therapy Is Beneficial for Unresectable Hepatocellular Carcinoma With Esophagogastric Varices.  FRONTIERS IN ONCOLOGY,  11,  2025. 
• 曾云青. DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer.  FRONTIERS IN GENETICS,  13,  2025. 
• 王忍忍. Safety and feasibility of early oral nutrition after endoscopic treatment for patients with liver cirrhosis: A historical prospective and comparative effectiveness study.  JOURNAL OF PARENTERAL AND ENTERAL NUTRITION,  2025. 
• 陶子文. Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease.  JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY,  10,  164, 2025. 

专利
• 暂无内容

著作成果
• 暂无内容

科研项目 More>>
• 焦虑诱发的BDNF-CRF脑肠互动在IBS发病机制中作用的研究,2014-08-15,2017-12-31
• PPI对肝硬化食管胃静脉曲张出血影响的多中心随机对照研究,2017-05-23,2023-05-23
• GP73依赖性溶瘤腺病毒携带SPK1shRNA对肝癌治疗的研究,2013-01-01,2015-12-31
• 联合干涉鞘氨醇激酶1和蛋白酶激活受体-2克服肝癌转移和耐药的研究,2013-01-01,2015-12-31
• 联合干涉鞘氨醇激酶1和蛋白酶激活受体-2克服肝癌转移和耐药的研究,2012-06-15,2015-06-30
• SPK-S1P信号调节肝癌细胞增殖、浸润及其机制的研究,2006-12-01,2009-12-31

科研团队
• 暂无内容